Loading clinical trials...
Loading clinical trials...
A Exploratory Clinical Trial Study on Apatinib in the Treatment of Metastatic Colorectal Cancer Who Have Progressed After Standard Second Line Therapy
Conditions
Interventions
Apatinib
Locations
1
China
Department of General Surgery, Zhongshan Hospital, Fudan University
Shanghai, China
Start Date
January 1, 2018
Primary Completion Date
June 30, 2019
Completion Date
December 31, 2019
Last Updated
January 18, 2018
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Fudan University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions